Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
China flag China · Delayed Price · Currency is CNY
11.42
-0.20 (-1.72%)
Nov 13, 2026, 3:00 PM CST

SHA:603079 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
816.35844.54827.4727.41738.02789.73
Revenue Growth
-2.79%2.07%13.75%-1.44%-6.55%-8.95%
Gross Profit
207.87209.64163.674.18110.27216.33
Operating Income
56.4567.0731.54-54.48-10.0760.49
Net Income
33.9462.1629.42-54.0631.4875.76
Earnings Per Share
0.180.350.17-0.320.180.44
EPS Growth
-46.73%105.88%---59.09%-62.39%

Revenue by Segment

Fiscal Year
FY 2025FY 2024
Period EndingDec '25 Dec '24
Vitamins
224.21244.71
Biological Preservatives and Functional Ingredients
524.74489.31
External Steam Sales
20.1837.19
Others
71.5355.4
Sales Materials
3.870.79
Total
844.54827.4

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
588.82650.31345.63326.74330.72534.83
Total Debt
356.8324.86263.23239.242.65168.85
Net Cash (Debt)
232.02325.4582.487.54288.07365.98
Net Cash Growth
-16.19%294.95%-5.86%-69.61%-21.29%-18.70%
Net Cash Per Share
1.231.830.480.521.652.13

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
135.04138.88147.8864.4240.7274.46
Capital Expenditures
-129.26-145.68-169.85-245.93-63.26-99.96
Free Cash Flow
5.78-6.8-21.97-181.51-22.54-25.5
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
25.46%24.82%19.77%10.20%14.94%27.39%
Operating Margin
6.92%7.94%3.81%-7.49%-1.36%7.66%
Pretax Margin
6.65%9.49%5.93%-6.23%4.95%10.14%
Profit Margin
4.16%7.36%3.56%-7.43%4.27%9.59%
FCF Margin
0.71%-0.80%-2.66%-24.95%-3.05%-3.23%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.1000.100-0.0600.0600.140
Dividend Per Share Growth
0%--0%-57.14%-60.00%
Dividend Yield
0.88%0.56%-0.41%0.48%0.81%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
63.6553.3677.51-68.2439.09
Forward PE
-55.6055.6055.6055.6055.60
PS Ratio
2.613.932.763.422.913.75